Home >

Drug Delivery

Drug development requires that pharma manufacturers make a critical decision about how their product is administered to patients. From oral modes of administration such as solid dose to parenteral routes involving injections, choices in drug delivery can make a major impact on new drug approvals or reformulations for existing products.

Articles

Pharma's molecular glue garden

With key players entering the ring and many clinical trials underway, the molecular glue garden is bound to bloom soon

Novo teams with Aspect on bioprinted diabetes treatments

The deal, focused on disease-modifying implantable bioprinted tissues, could be worth up to $2.7 billion

Advancing nanomedicine

Research into nanomaterials has opened the door to new therapeutic strategies

Developing a cell and gene therapy packaging strategy

Optimal packaging and labeling solutions help ensure the delivery of safe, effective viral vector products

mRNA boom: A double-edged sword

Did short-term solutions for COVID-19 stifle long-term mRNA success?

News

Progenity advances drug delivery system studies

Intranasal vaccines could be the next best thing in the fight against COVID-19

Lilly spends $1B on glucose-sensing insulin platform

FDA rejects Biogen's new MS drug formulation

Oxford to test inhaled version of COVID-19 vaccine

Pfizer working on powder form of COVID-19 vax

What’s next in adoptive cell therapy

Overcoming new manufacturing challenges as the cellular immunotherapy landscape expands

Assessing the nasal drug delivery landscape

New high-throughput screening models provide clinically reproducible and translatable results

Advancing drug delivery with lipid nanoparticles

Dr. Estelle Beguin, Strategic Marketing Manager for MilliporeSigma's SAFC Synthetic Lipids portfolio discusses lipid nanoparticles and the role they will play in the success of...

Back-to-basics on tablet press efficiency

How an objective assessment of equipment’s efficiency can make a big difference

Novo Nordisk buys Emisphere for drug delivery platform

Novo Nordisk has agreed to buy NJ-based Emisphere Technologies in order to gain control over a proprietary drug delivery technology that facilitates the enhanced oral absorption...